Lessons from the Introduction of Oral Transmucosal Fentanyl Citrate as Pre-Hospital Analgesia in the Mountain Rescue Service of England and Wales.

Authors

Michael Greene, David Whitmore, Christopher Boyle, Alistair Morris

Published in

Wilderness & environmental medicine. Pages 10806032261485256. Sep 22, 2026. Epub Sep 22, 2026.

Abstract

IntroductionPain management is important in pre-hospital care but studies demonstrate that it is often inadequate. This study describes the lessons learned from introducing oral transmucosal fentanyl citrate (OTFC) into Mountain Rescue England and Wales (MREW) as an analgesic alternative for rescue teams.MethodsThis was an observational health care improvement project. Data were extracted from the annual controlled drug return and the MREW incident database across three periods of time between 2004 and 2025. The primary outcomes were, OTFC adoption, as a measure of acceptability, changes in opioid use, the initial dose used and safety. Secondary outcomes examined opioid use with injury data and potential implications for mass-casualty incidents. Data were summarised descriptively and reported following the SQUIRE guidelines.ResultsOTFC was administered 685 times, for a variety of conditions and with the report of no significant adverse events. After full implementation (2025), 42 teams (89%) were using the drug. The most common initial dose used was 800 µg. The use of OTFC increased relative to other opioids but there was no evidence of increased overall opioid administration for lower leg injuries.ConclusionOTFC was widely adopted by rescue teams, suggesting it was a suitable drug to use in this environment. There was a change towards a more frequent use of OTFC and away from other opioids. The absence of significant adverse effects, suggests that OTFC can be used safely in selected patients by healthcare professionals and trained non-healthcare personnel. OTFC maybe a suitable drug to use in MCIs.

PMID:
42773063
Bibliographic data and abstract were imported from PubMed on 23 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.